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Cattle are important reservoirs of enterohemorrhagic Escherichia coli (EHEC) O157:H7 that cause disease
in humans. Both dairy and beef cattle are asymptomatically and sporadically infected with EHEC. Our
long-term goal is to develop an effective vaccine to prevent cattle from becoming infected and transmitting
EHEC O157:H7 to humans. We used passive immunization of neonatal piglets (as a surrogate model) to
determine if antibodies against EHEC O157 adhesin (intiminO157) inhibit EHEC colonization. Pregnant swine
(dams) with serum anti-intimin titers of <100 were vaccinated twice with purified intiminO157 or sham-
vaccinated with sterile buffer. IntiminO157-specific antibody titers in colostrum and serum of dams were
increased after parenteral vaccination with intiminO157. Neonatal piglets were allowed to suckle vaccinated or
sham-vaccinated dams for up to 8 h before they were inoculated with 106 CFU of a Shiga toxin-negative (for
humane reasons) strain of EHEC O157:H7. Piglets were necropsied at 2 to 10 days after inoculation, and
intestinal samples were collected for determination of bacteriological counts and histopathological analysis.
Piglets that ingested colostrum containing intiminO157-specific antibodies from vaccinated dams, but not those
nursing sham-vaccinated dams, were protected from EHEC O157:H7 colonization and intestinal damage.
These results establish intiminO157 as a viable candidate for an EHEC O157:H7 antitransmission vaccine.
Enterohemorrhagic Escherichia coli (EHEC) O157:H7 is a
common cause of bloody diarrhea and the most common cause
of hemolytic-uremic syndrome in humans in the United States
(1). EHEC strains can be foodborne pathogens, and cattle are
important reservoirs of EHEC O157:H7 strains. All EHEC
strains produce cytotoxins called Shiga toxins (Stx1 and Stx2),
previously called Shiga-like toxins (SLT-1 and SLT-2) or ve-
rotoxins (VT1 and VT2). Many EHEC strains, including
EHEC O157:H7, can attach intimately to host cell membranes
and efface microvilli and cytoplasm in a pattern referred to as
an attaching-and-effacing (A/E) lesion (18). EHEC intimin is
an outer membrane protein adhesin encoded by the eae gene
of EHEC (16) that is required for intestinal colonization and
for A/E activity of EHEC O157:H7 in piglets (6, 8, 9, 19) and
neonatal calves (6). Antibodies against intiminO157 signifi-
cantly reduce the adherence of E. coli O157:H7 strains, as well
as certain related strains, to HEp-2 cells (11). Based on this
observation, we hypothesize that a vaccine that contains in-
timinO157 may induce an immune response in cattle that will
prevent or decrease the level of intestinal colonization by E.
coli O157:H7. We speculate that the resultant diminution in
fecal shedding of EHEC O157:H7 by these animals could, in
turn, lead to a decrease in the transmission of EHEC O157:H7
and other A/E E. coli strains to humans.
In the study reported here, we tested the concept that anti-
intimin antibodies can protect animals from colonization with
EHEC O157:H7. For that purpose, we selected neonatal pig-
lets as the bacterial challenge model. Although pigs have not
been identified as a common reservoir of EHEC O157:H7
strains, the neonatal piglet EHEC infection model has been
used to demonstrate the critical role of intimin in EHEC
O157:H7 infections (6, 19). Furthermore, neonatal suckling
piglets are a good surrogate model for determining if antibod-
ies against intimin prevent EHEC colonization and disease.
The objectives of this investigation were twofold. First, we
sought to determine whether parenteral vaccination of preg-
nant swine (first-litter dams) with intiminO157 elicits anti-in-
timinO157 antibodies in their serum and colostrum. Second, we
wanted to assess whether piglets that ingest colostrum (first
milk) containing anti-intiminO157 antibodies are passively im-
munized and protected from EHEC O157:H7 infection and
disease. To prevent the development of Stx-mediated systemic
disease in the neonatal animals, we challenged them with an
Stx-negative E. coli O157:H7 strain. We felt confident that
substitution of this Stx strain for wild-type EHEC O157:H7
(which was done for humane purposes) would not compromise
our results because both Stx and Stx E. coli O157:H7 strains
similarly colonize and cause A/E lesions in the large intestines
of suckling piglets (3).
MATERIALS AND METHODS
IntiminO157 purification. The histidine-tagged intiminO157 protein RIHisEae
was purified as described previously (11, 20) and used for vaccination of pregnant
dams and for anti-intiminO157 dot blot assays. RIHisEae is a histidine-tagged
version of the entire intimin protein from EHEC O157:H7 strain 86-24 minus the
N-terminal 35 amino acids, which are thought to be part of a cleaved N-terminal
signal sequence (13, 20). For Western blot analysis of colostrum samples, a
histidine-tagged N-terminal two-thirds fragment of intimin and a histidine-
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tagged C-terminal one-third fragment of intimin were purified as described
previously (11).
Animals and vaccinations. Three crossbred pregnant dams (first-litter dams;
dams A, C, and E) were vaccinated intramuscularly with intiminO157 mixed with
TiterMax Gold adjuvant (500 g of intimin/dose) at 2 and 4 weeks prior to
farrowing (giving birth). Three pregnant dams (dams B, D, and F) were sham
vaccinated with Tris-buffered saline (TBS) mixed with adjuvant. Piglets naturally
farrowed at the National Animal Disease Center by these dams were allowed to
suckle colostrum before inoculation with E. coli O157:H7. One intiminO157-
vaccinated dam (dam C) had complications at farrowing and may not have
allowed all of the piglets to nurse freely prior to inoculation.
Colostrum and blood samples. Colostrum was collected from each dam at
parturition. Blood samples were collected from the dams prior to the first
vaccination (prevaccination) and at 7 to 11 days after farrowing when dams were
euthanatized (postvaccination). Blood samples were collected from all of the
piglets in the last two litters tested, one vaccinated litter (dam E) and one
sham-vaccinated litter (dam F), immediately before they were inoculated with E.
coli O157:H7. Colostral whey and sera were prepared as previously described
and stored at 80°C until tested (4).
Inoculation with E. coli O157:H7. All piglets were inoculated with 106 CFU of
Stx-negative E. coli O157:H7 strain 87-23 (17, 25) administered via stomach tube
after all of the piglets had nursed and before the piglets were 8 h old. Inocula
were prepared and stored as previously described (5). Piglets were returned to
the dam immediately after inoculation and observed clinically every 4 to 8 h.
Necropsy. Piglets were euthanatized with sodium pentobarbital and necrop-
sied at 2 to 10 days postinoculation (p.i.). Piglets were randomly assigned to each
of the necropsy groups. At necropsy, sections of the cecum were collected
aseptically for determination of bacterial counts and sections of the distal colon,
spiral colon, cecum, and ileum were collected for histopathologic examination
and immunoperoxidase (horseradish peroxidase [HRPO]) staining with anti-
O157:H7 antibody (see below).
Bacteriologic examination. Sorbitol-negative E. coli O157:H7 bacteria were
quantitated on sorbitol-MacConkey agar. Selected sorbitol-negative colonies
were tested for O157:H7 antigens by latex agglutination assay (5). Bacterial
colonization was defined as 106 CFU of inoculum bacteria/g of cecal tissue.
Because dilutions made in counting did not permit recovery of 104 CFU of E.
coli per g, tissues from which the inoculum strain was not recovered were
recorded as having 104 CFU/g of tissue.
Histologic studies. Tissues were fixed in neutral buffered 10% formalin, pro-
cessed by routine methods, sectioned, and stained with hematoxylin and eosin
(H&E). Stained tissue slides were coded and examined by light microscopy. A/E
lesions were scored from 0 (negative) to 4 (50% of villi or surface epithelium
affected) as previously described (5).
Immunoperoxidase staining with anti-O157:H7. O157:H7 bacteria were iden-
tified in paraffin-embedded, formalin-fixed tissues by indirect immunoperoxidase
staining with anti-O157:H7 as previously described (5).
Anti-intiminO157 dot blot assay. Anti-intiminO157 titers in swine serum and
colostrum were determined with a dot blot enzyme-linked immunosorbent assay.
Purified intiminO157 (100 l/dot; 12 g of intimin/ml in 0.1 M Tris–154 mM
NaCl, pH 7.4 [TBS]) was applied to nitrocellulose filters (BA85; Schleicher &
Schuell, Inc., Keene, N.H.) with a 96-well Milliblot apparatus (Millipore Corp.,
Bedford, Mass.). Unbound intimin was removed and additional binding sites on
the filters were blocked by three washes with 0.05% Tween 20 (Sigma, St. Louis,
Mo.) in TBS (TBS-T). All remaining incubations were for 1 h at 22°C. Diluted
serum or colostrum (100 l of serial 10-fold dilutions ranging from 102 to 104
or 105 per well) in TBS-T was added, and the mixture was incubated. After
three washes with TBS-T, filters were removed from the Millipore apparatus and
washed for an additional 10 min in TBS-T. Total bound immunoglobulin was
detected by sequential incubations with peroxidase-labeled goat anti-swine im-
munoglobulin G (heavy and light chains; Kirkegaard & Perry Laboratories,
Gaithersburg, Md.) and substrate (0.5 mg of 4-chloro-1-naphthol per ml, 0.015%
H2O2, and 16.7% methanol in TBS). The anti-intiminO157 titer is the reciprocal
of the highest dilution of serum or colostrum that yielded a purple (peroxidase-
positive) precipitate on a filter.
Adherence assays. The ability of porcine colostrum from intimin-vaccinated
dam A and sham-vaccinated dam B to inhibit the adherence of E. coli strain
87-23 to HEp-2 (human laryngeal epithelial) cells was assessed as described
previously (11). Briefly, colostrum samples were diluted 1:27 into 0.3 ml of
adherence medium (Eagle minimum essential medium, 1% mannose, 0.4% so-
dium bicarbonate), mixed with 4  106 bacteria of E. coli strain 87-23, and
incubated for 35 min at 37°C. The bacterium-colostrum mixtures were added to
monolayers of HEp-2 cells that were incubated for 3 h at 37°C and washed twice.
Fresh adherence medium with colostrum was added for a second 3-h incubation,
after which the cells were washed and stained as described previously. Adherence
was quantitated by determining the number of bacteria per HEp-2 cell, with at
least 250 HEp-2 cells and at least 600 bacteria counted per sample. The adher-
ence inhibition assays of these colostrum samples were done three times on
different days.
Western blot analysis. Colostrum samples from dams A and B were subjected
to Western blot analysis for reactivity with whole-cell lysates of EHEC and for
reactivity with purified intimin protein. Whole-cell bacterial lysates of wild-type
EHEC O157:H7 strain 86-24 (14) and its isogenic eae mutant derivative 86-24
eae10 (19) were prepared and loaded onto sodium dodecyl sulfate-polyacryl-
amide gels as described previously (11). Proteins separated by sodium dodecyl
sulfate-polyacrylamide gel electrophoresis were blotted onto nitrocellulose and
processed for immunoblot analysis with visualization by chemiluminescence as
described previously (11). A 1:7,500 dilution of each colostrum sample was used,
followed by an anti-swine secondary antibody (Sigma). Western blots were
scanned, and images of the blots were arranged and labeled with Adobe Photo-
shop version 5.0.2 for Macintosh.
RESULTS
Anti-intiminO157 titers. As shown in Table 1, the serum
anti-intiminO157 titers of all of the pregnant dams were 100
before they were vaccinated. At the time of farrowing, all of
the intiminO157-vaccinated dams had colostral anti-intiminO157
titers of 100,000 and all of the sham-vaccinated dams had
titers of 100. The serum anti-intiminO157 titers of the vacci-
nated dams after they had farrowed were10,000, but those of
the sham-vaccinated dams were 100. All seven of the piglets
that nursed a vaccinated dam (dam E) and were at least 2 h old
when they were inoculated with E. coli O157:H7 had serum
anti-intiminO157 titers of 10,000 at the time they were chal-
lenged. Two piglets in this same litter that were inoculated
before they were 2 h old had a titer of 100. All eight of the
piglets nursing sham-vaccinated dam F had titers of 100.
Adherence of E. coli strain 87-23 to HEp-2 cells in vitro in
the presence of colostrum. A small but reproducible difference
in the number of adherent bacteria was observed in the pres-
ence of colostrum from the intiminO157-immunized dam com-
pared to colostrum from the sham-vaccinated dam (35% fewer
adherent bacteria in the presence of colostrum from the in-
timinO157-immunized dam, as averaged from the three repli-
cate assays; P  0.05; data not shown). Neither colostrum
sample agglutinated the bacteria, as assessed by slide aggluti-
nation assays. Further, the growth of strain 87-23 in the pres-
ence of colostrum from the intiminO157-immunized dam was
comparable to that in the presence of colostrum from the
TABLE 1. Anti-intiminO157 titers in serum and colostrum of








A 100 10,000 100,000
C 100 10,000 100,000
E 100 10,000 100,000
Sham (TBS)
B 100 100 100
D 100 100 100
F 100 100 100
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sham-vaccinated dam, as determined from colony counts after
growth in adherence medium.
Western blot analysis. Colostrum samples from one intimin-
vaccinated and one sham-vaccinated dam (dams A and B)
were also analyzed by Western blotting. The colostrum from
the intiminO157-vaccinated dam, but not that from the sham-
vaccinated dam, reacted with intimin in a whole-cell lysate of
EHEC O157:H7 (Fig. 1A). The immune colostrum contained
antibodies that recognized N- and C-terminal portions of in-
timinO157, as demonstrated by reactivity against purified in-
timin fragments (Fig. 1B).
Clinical and gross pathological observations. All but one of
the piglets remained clinically healthy following inoculation
with Stx-negative E. coli O157:H7 strain 87-23. One weak and
depressed piglet in a vaccinated litter (litter A) had mild diar-
rhea between 8 and 24 h after inoculation but not between 24
and 48 h when it was necropsied. This pig and two other piglets
(one of which was lame) from the same litter had moderate
colonic edema and hyperemia when necropsied at 2 or 3 days
after inoculation (but none of these three pigs were colonized
with the inoculum strain or had A/E lesions).
Bacterial colonization. Table 2 shows the numbers of inoc-
ulum bacteria that were recovered from the suckling piglets.
Most (25 of 30) of the piglets nursing sham-vaccinated dams
were colonized by E. coli O157:H7 (i.e., had 106 CFU of
inoculum bacteria/g of cecal tissue) at 2 to 10 days after inoc-
ulation. The five piglets that were not colonized were necrop-
sied at either 2 or 3 days after inoculation. In contrast, only 6
of the 25 piglets nursing intiminO157-vaccinated dams were
colonized or had A/E lesions at 2 to 10 days after inoculation.
Five of these six colonized piglets were from litter C, the litter
that might not have had free access to colostrum before chal-
lenge (see Materials and Methods). No E. coli O157:H7 bac-
teria (i.e., 104 CFU of inoculum bacteria/g of cecal tissue)
were recovered from 15 (including the 2 piglets in litter E that
had low serum anti-intiminO157 titers) of the 19 piglets suckling
vaccinated dams that were not colonized.
A/E lesions. Most (25 of 30) piglets nursing the three sham-
vaccinated control dams had A/E lesions in the large intestines
at 2 to 10 days after inoculation with E. coli O157:H7 (Table 2
and Fig. 2). All sham-vaccinated piglets that had 106 CFU of
O157:H7/g of cecal tissue had A/E lesions. In contrast, only 8
of the 25 piglets nursing intiminO157-vaccinated dams had A/E
lesions. Three of these piglets had rare O157:H7-positive A/E
lesions that were detected only by HRPO staining. No A/E
lesions were seen in the two piglets in litter E that had low
serum anti-intiminO157 titers at the time of inoculation. A/E
lesions were found in all cecal tissues that had at least 106 CFU
of inoculum bacteria/g of cecal tissue. O157:H7-positive A/E
lesions were identified by HRPO in all tissue sections in which
A/E lesions were detected by H&E staining. As shown in Fig.
2, the A/E scores of vaccinated piglets with A/E lesions were
considerably lower than those of the sham-vaccinated piglets.
Five of the piglets that nursed vaccinated dam C, but none of
the piglets that nursed the other two vaccinated dams, had A/E
lesions that were detected by H&E staining. Two additional
piglets from litter C and one piglet from litter A (clinically
normal and without gross lesions) had rare O157:H7-positive
A/E lesions that were detected only by HRPO staining.
FIG. 1. Western blot analysis of colostrum. Colostrum samples
from an intimin-vaccinated dam (lanes 1 and 2) and a sham (TBS)-
vaccinated dam (lanes 3 and 4) were assayed by Western blotting.
(A) Reactivity of colostrum samples against whole-cell lysates of
EHEC O157: H7 strain 86-24 (lanes 1 and 3) and intimin mutant strain
86-24 eae10 (lanes 2 and 4). The region of the blot containing intimin
(arrow) is shown; the colostrum also reacted with lower-molecular-
weight bands in the lysates. The band migrating just below intimin may
be a cross-reacting band. (B) Reactivity of colostrum samples with a
purified N-terminal two-thirds fragment of intimin (lanes 1 and 3) and
a purified C-terminal one-third fragment of intimin (lanes 2 and 4)
from EHEC strain 86-24.
TABLE 2. Effect of vaccination of pregnant dams with intiminO157
on experimental E. coli O157:H7 infection in suckling piglets
Vaccination
and litter(s)
No. of piglets positive/no. tested









A  C  E 6/25c 5/20 1/5 8/25c,d 6/20d 2/5
A 1/8 1/8 NDe 1/8d 1/8d ND
C 5/8 4/6 1/2 7/8d 5/6d 2/2
E 0/9 0/6 0/3 0/9 0/6 0/3
Sham (TBS)
B  D  F 25/30 17/22 8/8 26/30 18/22 8/8
B 8/11 6/9 2/2 9/11 7/9 2/2
D 9/9 6/6 3/3 9/9 6/6 3/3
F 8/10 5/7 3/3 8/10 5/7 3/3
a 106 CFU of inoculum bacteria/g of cecum.
b A/E lesions identified as O157:H7 by immunostaining.
c Significantly different from sham-vaccinated piglets (P  0.05 [chi-square
analysis]).
d A/E lesions were detected only by HRPO, and not by H&E staining, in one
piglet in litter A and two in litter C.
e ND, not done.
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DISCUSSION
A vaccine preparation consisting of intiminO157 mixed with
TiterMax Gold adjuvant and administered parenterally at 2
and 4 weeks prior to farrowing was immunogenic in pregnant
swine. Most suckling piglets that ingested colostrum containing
anti-intiminO157 antibodies from intiminO157-vaccinated dams
were not colonized and did not develop intestinal lesions when
they were challenged with E. coli O157:H7. The two piglets
from litter E that were inoculated before they were 2 h old may
have had a serum anti-intiminO157 titer of only 100 at the time
of inoculation because they had not yet had time to absorb
antibody from colostrum into the serum. They might have had
higher serum titers if sampled later. This is supported by the
observation that they were protected from colonization after
challenge. The protective antibodies were most likely transmit-
ted via colostrum because immunoglobulins are not transmit-
ted in utero to the fetuses of healthy sows.
Colostrum from the one intiminO157-vaccinated dam that we
tested, but not that from a sham-vaccinated dam, inhibited the
adherence of E. coli O157:H7 strain 87-23 to HEp-2 cells. This
colostrum contained antibodies against the C-terminal third of
intimin, the region that is known to be critical for interaction
with mammalian cells (7, 10). The inhibitory effect on adher-
ence did not appear to be due to agglutination or inhibition of
bacterial growth by the colostrum. These observations support
the hypothesis that the presence of antibodies against in-
timinO157 in the intestines of suckling piglets inhibits bacterial
adherence. The effects of antibodies on adherence in vitro
(35% inhibition) were weaker than those observed in vivo
(seven of eight piglets were protected from adherence and
colonization).
None of the pregnant dams in this study had preexisting
anti-intiminO157 titers of 100, but all of the intiminO157-vac-
cinated dams had colostral anti-intiminO157 titers of 100,000
at farrowing. However, one pregnant dam was excluded from
an earlier pilot study because it had an anti-intiminO157 titer of
1:10,000 prior to sham vaccination (with TBS and adjuvant)
and a colostral anti-intiminO157 titer of 100,000 at farrowing.
The presence of anti-intiminO157 antibodies in a nonvaccinated
pig is consistent with previous reports that some porcine E. coli
isolates have A/E activity and/or contain the eae gene, which
encodes intimin (15, 21, 22, 26), and could be reservoirs of
EHEC associated with human infections (2, 23, 24).
In this study, as in previous studies, the presence of A/E
lesions containing O157: H7-positive bacteria correlated with
the number of inoculum bacteria recovered from the ceca of
piglets inoculated with E. coli O157:H7 bacteria. A/E lesions
were seen in most piglets that had 106 CFU of O157:H7/g of
cecum but rarely in ones with fewer bacteria.
Consistent with our earlier observations (3), most of the
sham-vaccinated suckling piglets were colonized and had in-
testinal lesions by 3 days p.i. but showed no signs of disease. It
was somewhat surprising that all of the sham-vaccinated suck-
ling piglets examined between 6 and 10 days p.i. were colonized
with O157:H7 bacteria and had A/E lesions. Apparently, E.
coli O157:H7 was not cleared from the large intestines of
neonatal piglets (based on high cecal counts) as rapidly as it is
thought to be cleared from some EHEC-infected humans (as
estimated by negative fecal cultures). The inability to recover
EHEC O157:H7 from the feces of some human patients with
bloody diarrhea or hemolytic-uremic syndrome has been at-
tributed to clearance of the causative EHEC bacteria by the
time the patients seek medical care and samples are collected
for culture. It was encouraging to see that piglets nursing the
vaccinated dams were still not colonized at 9 to 10 days after
inoculation.
The long-term goal of our research is to develop a means for
reducing the transmission of E. coli O157:H7 from cattle to
humans. The concept that antibodies to intiminO157 may block
colonization of animals with O157:H7 was strongly supported
by the passive immunization studies with suckling piglets de-
scribed here. Indeed, the results of these experiments clearly
FIG. 2. Effect of intiminO157 vaccination of pregnant gilts on the distribution and intensity of A/E lesions in suckling piglets at 3 to 10 days p.i.
A/E scores reflect the extent of villi or surface epithelium affected, as estimated by examination of H&E-stained sections. Scoring: 1, detected
only in HRPO-stained sections; 2, 10% of the villi or surface epithelium affected; 3, 10 to 50% of the villi or surface epithelium affected; 4,
50% of the villi or surface epithelium affected.
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demonstrated that piglets that ingested maternal antibodies
against intiminO157 were protected from colonization and in-
testinal damage following experimental inoculation with an
intimin-producing, nontoxigenic E. coli O157:H7 strain. These
results establish intiminO157 as a viable candidate for an EHEC
O157:H7 antitransmission vaccine. Recent evidence showing
that active immunization of mice with intimin prevents colo-
nization by the intimin-positive mouse pathogen Citrobacter
rodentium (12) further bolsters the idea of using intimin in
vaccines against EHEC pathogens. For humane reasons, we
have not tested the vaccine against Stx-positive strains in neo-
natal piglets because they are highly sensitive to Stx-mediated
neurological disease (3). However, since cattle appear to be
resistant to Stx-mediated disease, we will use Stx-positive
EHEC strains in future studies to determine if anti-intiminO157
antibodies can also prevent EHEC colonization and transmis-
sion in cattle.
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